Shanghai Fosun Pharmaceutical (Group) Co Balance Sheet
Shanghai Fosun Pharmaceutical (Group) Co's total assets for Q3 2024 were ¥115.26B, a decrease of -0.24% from the previous quarter. SFOSF total liabilities were ¥56.07B for the fiscal quarter, a -1.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23
Dec 22
Dec 21
Dec 20
Dec 19
Total Assets
¥ 113.47B
¥ 107.16B
¥ 93.29B
¥ 83.69B
¥ 76.12B
Total Liabilities
¥ 56.85B
¥ 53.05B
¥ 44.92B
¥ 37.70B
¥ 36.92B
Total Equity Gross Minority
¥ 56.62B
¥ 54.11B
¥ 48.38B
¥ 45.98B
¥ 39.20B
Other Metrics
¥ ―
¥ ―
¥ ―
¥ ―
¥ ―
Currency in CNY
Shanghai Fosun Pharmaceutical (Group) Co Debt to Assets